BioSpecifics Technologies
Biopharmaceutical company that has developed injectable collagenase for twelve clinical indications to date.
Launch date
Employees
Market cap
-
Enterprise valuation
$540m (Public information from Oct 2020)
Hempstead New York (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
$540m Valuation: $540m | Acquisition | ||
Total Funding | - |
Recent News about BioSpecifics Technologies
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.